Review Article
Volume 4 Issue 5 - 2020
Contemporary Perspectives in Diabetes Mellitus
Gajjela Sirichandana1* and Nikhil Kumar Vanjari2
1Pharm-D, Department of Clinical Pharmacy, Vaageswari College of Pharmacy, Karimnagar, Telangana, India
2Pharm-D, Clinical Assistant professor, Diabetes Educator, Department of Clinical Pharmacy, Vaageswari College of Pharmacy, Karimnagar, Telangana, India
*Corresponding Author: Gajjela Sirichandana, Pharm-D, Department of Clinical Pharmacy, Vaageswari College of Pharmacy, Karimnagar, Telangana, India.
Received:February 26, 2020; Published: April 28, 2020




Abstract

Diabetes mellitus is a deep-rooted disorder characterized by hyperglycemia. It currently a worldwide public health issue and may be a burden to society due to its disabling and customary complications. Diabetes is multifactorial and also induces the onset of other diseases. Current review specialize in gut microbiota induced diabetes. Aside from digestion, the gut microbiota is vital in up keeping the optimal state of host health, mostly fewer Firmicutes, including Clostridia, Betaproteobacteria and the Gram-negative Bacteroidetes and Proteobacteria plays a major role in pathogenesis of diabetes, but it’s also implicated within the pathogenesis of various metabolic diseases, like obesity, chronic renal disorder, diabetes and atherosclerosis and intestinal diseases, like inflammatory bowel diseases and colorectal cancer. This review also focuses on new delivery systems like pump therapy, aerosols and new monitoring systems like continuous blood glucose monitoring, HbA1c measurement.

Keywords: Gut Microbial Flora; Diabetes; Insulin Pump Therapy; Continuous Blood Sugar Monitoring

References

  1. Aw W and Fukuda S. “Understanding the role of the gut ecosystem in diabetes mellitus”. Journal of Diabetes Investigation1 (2018): 5-12.
  2. College NR., et al. “Davidson's principles and practice of medicine”. Edinburgh; New York: Churchill Livingstone/Elsevier (2010).
  3. Qin J., et al. “A human gut microbial gene catalogue established by metagenomic sequencing”. Nature 464 (2010): 59-65.
  4. Aw W and Fukuda S. “An integrated outlook on the metagenome and metabolome of intestinal diseases”. Diseases 3 (2015): 341-359.
  5. Turnbaugh PJ., et al. “An obesity associated gut microbiome with increased capacity for energy harvest”. Nature 444 (2006): 1027-1031.
  6. Ridaura VK., et al. “Gut microbiota from twins discordant for obesity modulate metabolism in mice”. Science 341 (2013): 1241214.
  7. Turnbaugh PJ., et al. “A core gut microbiome in obese and lean twins”. Nature 457 (2009): 480-484.
  8. Wen L., et al. “Innate immunity and intestinal microbiota in the development of type 1 diabetes”. Nature 455 (2008): 1109-1113.
  9. Qin J., et al. “A metagenome-wide association study of gut microbiota in type 2 diabetes”. Nature 490 (2012): 55-60.
  10. Karlsson FH., et al. “Gut metagenome in European women with normal, impaired and diabetic glucose control”. Nature 498 (2013): 99-103.
  11. Wang F., et al. “Gut bacterial translocation contributes to microinflammation in experimental uremia”. Digestive Diseases and Sciences 57 (2012): 2856-2862.
  12. Mishima E., et al. “Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD”. American Society of Nephrology 26 (2015): 1787-1794.
  13. Tang WH., et al. “Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk”. The New England Journal of Medicine 368 (2013): 1575-1584.
  14. Koeth RA., et al. “Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis”. Nature Medicine 19 (2013): 576-585.
  15. Wang Z., et al. “Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis”. Cell 163 (2015): 1585-1595.
  16. Molodecky NA., et al. “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review”. Gastroenterology 142 (2012): 46-54.
  17. Scanlan PD., et al. “Culture independent analysis of the gut microbiota in colorectal cancer and polyposis”. Applied and Environmental Microbiology 10 (2008): 789-798.
  18. Belcheva A., et al. “Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells”. Cell 158 (2014): 288-299.
  19. Schulz MD., et al. “High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity”. Nature 514 (2014): 508-512.
  20. King DE., et al. “Trends in dietary fiber intake in the United States, 1999-2008”. Journal of the Academy of Nutrition and Dietetics 112 (2012): 642-648.
  21. McGill CR., et al. “Ten-year trends in fiber and whole grain intakes and food sources for the United States population: National Health and Nutrition Examination Survey 2001-2010”. Nutrients 7 (2015): 1119-1130.
  22. Tan J., et al. “The role of short chain fatty acids in health and disease”. Advances in Immunology 121 (2014): 91-119.
  23. Frank DN., et al. “Investigating the biological and clinical significance of human dysbiosis”. Trends in Microbiology 19 (2011): 427-434.
  24. Jiang W., et al. “Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease”. Scientific Reports 5 (2015): 8096.
  25. Mikkelsen KH., et al. “Use of antibiotics and risk of type 2 diabetes: a population-based case control study”. The Journal of Clinical Endocrinology and Metabolism 100 (2015): 3633.
  26. Larsen N., et al. “Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults”. PLoS ONE 5 (2010): e9085.
  27. Vrieze A., et al. “Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity”. Journal of Hepatology 60 (2014): 824-831.
  28. Alkanani AK., et al. “Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes”. Diabetes 10 (2015): 3510-3520.
  29. De Goffau MC., et al. “Aberrant gut microbiota composition at the onset of type 1 diabetes in young children”. Diabetologia8 (2014): 1569-1577.
  30. Maffeis C., et al. “Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes”. Diabetes Metabolism Research and Reviews 7 (2016): 700-709.
  31. Leiva-Gea I., et al. “Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case–control study”. Diabetes Care11 (2018): 2385-2395.
  32. Cole DK., et al. “Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity”. Journal of Clinical Investigation 6 (2016): 2191-2204.
  33. Hamer HM., et al. “Review article: the role of butyrate on colonic function”. Alimentary Pharmacology and Therapeutics2 (2008): 104-119.
  34. Furusawa Y., et al. “Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells”. Nature 7480 (2013): 446-450.
  35. Brestoff JR and Artis D. “Commensal bacteria at the interface of host metabolism and the immune system”. Nature Immunology 7 (2013): 676-684.
  36. Wong JM., et al. “Colonic health: fermentation and short chain fatty acids”. Journal of Clinical Gastroenterology 3 (2006): 235-243.
  37. Arpaia N., et al. “Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation”. Nature 504 (2013): 451.
  38. Atarashi K., et al. “Induction of colonic regulatory T cells by indigenous clostridium species”. Science 6015 (2011): 33741.
  39. Izcue A., et al. “Regulatory lymphocytes and intestinal inflammation”. Annual Review of Immunology 27 (2009): 313-338.
  40. Smith PM., et al. “The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis”. Science6145 (2013): 569-573.
  41. Finelli C., et al. “Should visceral fat be reduced to increase longevity?” Ageing Research Reviews 4 (2013): 996-1004.
  42. Yuxin Wang., et al. “Pseudoflavonifractor and Lactobacillus intestinalis: Three Potential Biomarkers of Gut Microbiota That Affect Progression and Complications of Obesity-Induced Type 2 Diabetes Mellitus”. Diabetes, Metabolic Syndrome and Obesity 13 (2020): 835-850.
  43. Wei M. “Enterococcus hirae WEHI01 isolated from a healthy Chinese infant ameliorates the symptoms of type 2 diabetes by elevating the abundance of Lactobacillales in rats”. Journal of Dairy Science 4 (2020): 2969-2981.
  44. Weissberg-Benchell J., et al. “Insulin pump therapy: a meta-analysis”. Diabetes Care 2694 (2003): 1079-1087.
  45. Bode BW., et al. “Reduction in severe hypoglycaemia with long term continuous subcutaneous insulin infusion in type 1 diabetes”. Diabetes Care 19 (1996): 324-327.
  46. Ludvigsson J and Haas R. “Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients”. Pediatrics 111 (2003): 933-938.
  47. Chase HP., et al. “Continuous subcutaneous glucose monitoring in children with type 1 diabetes”. Pediatrics 107 (2001): 222-226.
Citation: Gajjela Sirichandana and Nikhil Kumar Vanjari. “Contemporary Perspectives in Diabetes Mellitus". EC Nutrition 4.5 (2020): 26-32.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 06, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.